Back to News
Mar 18, 2026 4:00 PM

Why Is CytomX Therapeutics Stock Falling On Wednesday?

CytomX Therapeutics Inc. (NASDAQ:CTMX) shares are down on Wednesday following a capital raise of $250 million.

On Tuesday, CytomX Therapeutics announced a public offering of 45.9 million shares at $5.30 per share, pre-funded warrants to purchase 1.179 million shares.

The company will use the proceeds for the continued development of Varseta-M and other pipeline programs.

CytomX Colorectal Data Shows 32% Response

The company’s stock rallied following recent data on colorectal cancer treatment.

The latest data revealed positive response rates in colorectal cancer patients, with expansion cohorts showing a 32% response rate at ...